Cite
PMS85 - Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database.
MLA
Feldman, Sr, et al. “PMS85 - Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database.” Value in Health, vol. 20, no. 9, Oct. 2017, p. A541. EBSCOhost, https://doi.org/10.1016/j.jval.2017.08.808.
APA
Feldman, S., Bonafede, M., Pelletier, C., Mehta, R., Brouillette, M., Smith, D., Wilson, K., & Ni, Q. (2017). PMS85 - Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database. Value in Health, 20(9), A541. https://doi.org/10.1016/j.jval.2017.08.808
Chicago
Feldman, Sr, Mm Bonafede, C Pelletier, R Mehta, M Brouillette, D Smith, Kl Wilson, and Q Ni. 2017. “PMS85 - Comparison of Persistence And Adherence In Biologic Naïve Patients With Psoriatic Arthritis Initiating Apremilast or Biologics In A US Administrative Claims Database.” Value in Health 20 (9): A541. doi:10.1016/j.jval.2017.08.808.